Growth-hormone releasing factor does not antagonize somatostatin effects on pancreatic and gastric secretions
- PMID: 2866110
- DOI: 10.1007/BF01950030
Growth-hormone releasing factor does not antagonize somatostatin effects on pancreatic and gastric secretions
Abstract
The effect of human GRF 44 upon somatostatin-inhibited pancreatic and gastric secretions was studied in rats with chronic fistulas. GRF did not show any antagonist action of somatostatin on these gastro-intestinal organs. GRF alone had a small inhibitory effect on gastric acid output.
Similar articles
-
Effect of somatocrinin with or without a somatostatin antiserum on pancreatic growth.Pancreas. 1986;1(1):13-9. doi: 10.1097/00006676-198601000-00004. Pancreas. 1986. PMID: 2437558
-
Effects of growth hormone releasing factor on pancreatic secretion in vivo and in vitro.Regul Pept. 1989 Mar;24(3):301-11. doi: 10.1016/0167-0115(89)90226-7. Regul Pept. 1989. PMID: 2469109
-
Synthetic pancreatic growth hormone-releasing factor (GRF-40) stimulates the secretion of the endocrine pancreas.Diabetes. 1986 Jan;35(1):119-23. doi: 10.2337/diab.35.1.119. Diabetes. 1986. PMID: 2866996
-
Effect of somatocrinin and a somatostatin antiserum on duodenal and gastric growth in the rat.Regul Pept. 1986 Dec 1;16(1):51-67. doi: 10.1016/0167-0115(86)90194-1. Regul Pept. 1986. PMID: 2433713
-
The effects of growth hormone (GH)-releasing peptides on GH secretion in perifused pituitary cells of adult male rats.Endocrinology. 1984 Oct;115(4):1432-8. doi: 10.1210/endo-115-4-1432. Endocrinology. 1984. PMID: 6148232